Lineage Cell Therapeutics
LCTX
#8710
Rank
C$0.17 B
Marketcap
$0.79
Share price
-1.70%
Change (1 day)
-46.87%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Total debt

Total debt on the balance sheet as of September 2024 : C$3.95 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's total debt is C$3.95 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Lineage Cell Therapeutics - Total debt on balance sheet (from 2001 to 2024)

Total debt by year

Year Total debt Change
2023-12-31C$3.91 M-25.94%
2022-12-31C$5.28 M48.05%
2021-12-31C$3.57 M-26.78%
2020-12-31C$4.87 M-27.74%
2019-12-31C$6.74 M118.76%
2018-12-31C$3.08 M60.08%
2017-12-31C$1.92 M-63.98%
2016-12-31C$5.35 M-24.41%
2015-12-31C$7.07 M1057.49%
2014-12-31C$0.61 M
2013-12-31N/A
2008-12-31C$2.29 M220.76%
2007-12-31C$0.71 M
2003-12-31C$3.48 M1.7%
2002-12-31C$3.42 M24.21%
2001-12-31C$2.75 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
C$4.48 M 13.49%๐Ÿ‡บ๐Ÿ‡ธ USA